½ÃÀ庸°í¼­
»óǰÄÚµå
1654727

¼¼°èÀÇ °í¸· Àý°³¿ë Á¦Ç° ½ÃÀå-2025-2033³â

Global Tympanostomy Products Market - 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: DataM Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 176 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼¼°è °í¸· Àý°³ Á¦Ç° ½ÃÀåÀº 2024³â¿¡ 9,876¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. 2025-2033³â°£ 3.37%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2033³â¿¡´Â 1¾ï 3,276¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°í¸· Àý°³¼úÀº ¸¸¼º ±Í °¨¿°À̳ª ÁßÀÌ¿¡ °íÀÎ ¾×ü¸¦ Ä¡·áÇϱâ À§ÇØ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â ÀÇ·á ½Ã¼ú·Î, ÁÖ·Î ¼Ò¾Æ¿¡°Ô ¸¹ÀÌ »ç¿ëµË´Ï´Ù. ÀÌ ½Ã¼úÀº °í¸·¿¡ ÀÛÀº Àý°³¸¦ ÅëÇØ ¾×ü¸¦ ¹èÃâÇϰí ȯ±â Æ©ºê ¶Ç´Â ÀÌ¾î Æ©ºê¶ó°í ¾Ë·ÁÁø ÀÛÀº Æ©ºê¸¦ »ðÀÔÇÏ¿© ÁßÀÌÀÇ È¯±â¸¦ À¯ÁöÇÕ´Ï´Ù. À̸¦ ÅëÇØ ¾×ü°¡ ´õ ÀÌ»ó °í¸·¿¡ °íÀÌ´Â °ÍÀ» ¹æÁöÇϰí, °¨¿° Àç¹ßÀÇ À§ÇèÀ» ÁÙÀ̸ç, ¾Ð¹Ú°¨°ú ÅëÁõÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

°í¸· Àý°³¿ë Á¦Ç° ½ÃÀå¿¡´Â ½Ç¸®ÄÜ, ƼŸ´½, ±×·Î¹Ô µîÀÇ Àç·á·Î ¸¸µé¾îÁø ´Ù¾çÇÑ À¯ÇüÀÇ Åë±â Æ©ºê µî ½Ã¼ú¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Á¦Ç°ÀÌ Æ÷ÇԵ˴ϴÙ. ±âŸ ÁÖ¿ä Á¦Ç°À¸·Î´Â Àý°³¸¦ À§ÇÑ ¼ö¼ú ±â±¸, °¨¿°À» ¿¹¹æÇϱâ À§ÇÑ ±¹¼Ò Ç×»ýÁ¦, ȯÀÚÀÇ Æí¾ÈÇÔÀ» À§ÇÑ ¸¶ÃëÁ¦ µîÀÌ ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ

±Í °¨¿° Áõ°¡

ƯÈ÷ ¼Ò¾Æ¿¡¼­ ±Í °¨¿° Áõ°¡°¡ °í¸· Àý°³¿ë Á¦Ç° ½ÃÀåÀ» Å©°Ô °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±Í °¨¿°Àº À¯¾Æ¿¡°Ô ÈçÇÑ ¹®Á¦À̸ç, ¹Ýº¹ÀûÀ¸·Î ¹ß»ýÇϸé ü¾× ÃàÀû ¹× ³­Ã»°ú °°Àº ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â ¹Ì±¹ ±¹¸³º¸°Ç¿ø º¸°í¼­¿¡ µû¸£¸é, ¸¸¼º È­³ó¼º ÁßÀÌ¿°(OM)ÀÇ Àü ¼¼°è ¹ßº´·üÀº 1,000¸í´ç 4.76¸í, ¾à 3,100¸¸ °Ç¿¡ ´ÞÇÏ´Â °ÍÀ¸·Î º¸°íµÆ½À´Ï´Ù. ÀÌ Áß 22.6%´Â 5¼¼ ¹Ì¸¸ ¼Ò¾Æ¿¡¼­ ¸Å³â ¹ß»ýÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °¨¿°ÀÌ ºó¹øÇÏ°Ô ¹ß»ýÇÔ¿¡ µû¶ó Àå±âÀûÀÎ ¹®Á¦¸¦ ¿¹¹æÇϰí û·ÂÀ» ȸº¹½ÃŰ´Â °í¸· Àý°³¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ½Ã¼úÀº °í¸·¿¡ ÀÛÀº Åëdz°üÀ» »ðÀÔÇÏ¿© ±ÍÀÇ ¹è¾×À» °³¼±Çϰí ÇâÈÄ °¨¿°À» ¿¹¹æÇÕ´Ï´Ù.

°í¸· Àý°³ Æ©ºê ¹× ±âŸ °ü·Ã Á¦Ç°À» ÇÊ¿ä·Î ÇÏ´Â ¾î¸°À̰¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ Àåºñ ½ÃÀåÀº È®´ëµÇ´Â Ãß¼¼ÀÔ´Ï´Ù. Ä¡·áµÇÁö ¾ÊÀº ±Í °¨¿°ÀÇ Àå±âÀûÀÎ ¿µÇâ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó È¿°úÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ Çʿ伺ÀÌ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ±â¼úÀÇ ¹ßÀü°ú ÇÔ²² º¸´Ù ´ú ħ½ÀÀûÀÎ »õ·Î¿î ÀΰøÈ£Èí±â Æ©ºê°¡ °³¹ßµÇ¾î ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ°í ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ¾ÕÀ¸·Îµµ Áö¼ÓµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ƯÈ÷ À¯¾ÆÀÇ ±Í °¨¿°ÀÌ ¿©ÀüÈ÷ ¸¹±â ¶§¹®¿¡ ÀÌ·¯ÇÑ Ãß¼¼´Â °è¼ÓµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

°³¹ßµµ»ó±¹ÀÇ ³·Àº ÀÎÁöµµ

½ÅÈï±¹¿¡¼­´Â ÀÎÁöµµ°¡ ³·±â ¶§¹®¿¡ ȯÀÚ¿Í ÀÇ·áÁøÀÌ ½Ã¼úÀÇ ÀÌÁ¡À» ÀνÄÇÏÁö ¸øÇÏ¿© °í¸· Àý°³ Á¦Ç° ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸¹Àº Àú¼Òµæ Áö¿ª¿¡¼­´Â ¾Æµ¿ÀÇ ³­Ã» ¹× ¹ß´Þ Áö¿¬ ¹æÁö¿Í °°Àº Àå±âÀûÀÎ ÀÌÁ¡¿¡ ´ëÇÑ Áö½ÄÀÌ ºÎÁ·ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ´ú È¿°úÀûÀÎ Ä¡·á¹ýÀÌ »ç¿ëµÇ¾î Àüü ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå Á¤ÀÇ¿Í °³¿ä

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • ¿µÇ⠺м®

Á¦5Àå »ê¾÷ ºÐ¼®

  • PorterÀÇ Five Forces ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • °¡°Ý ºÐ¼®
  • ƯÇ㠺м®
  • ±ÔÁ¦ ºÐ¼®
  • SWOT ºÐ¼®
  • ¹ÌÃæÁ· ¿ä±¸

Á¦6Àå Á¦Ç° À¯Çüº°

  • Tympanostomy Tubes
  • Tube Applicators / Inserters
  • ±âŸ

Á¦7Àå ¼ÒÀç À¯Çüº°

  • ƼŸ´½
  • ºÒ¼Ò¼öÁö
  • ½Ç¸®ÄÜ
  • ½ºÅ×Àθ®½º ½ºÆ¿
  • ±âŸ

Á¦8Àå ¿ëµµº°

  • ¸¸¼º ÁßÀÌ¿°
  • Àç¹ß¼º ±Þ¼º ÁßÀÌ¿°
  • À¯½ºÅ¸Å°¿À°ü ±â´É Àå¾Ö
  • ±âŸ

Á¦9Àå ÃÖÁ¾ ¿ëµµº°

  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Àü¹® Ŭ¸®´Ð
  • ±âŸ

Á¦10Àå Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ³²¹Ì
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå °æÀï ±¸µµ

  • °æÀï ½Ã³ª¸®¿À
  • ½ÃÀå ÇöȲ ¹× Á¡À¯À² ºÐ¼®
  • ÀμöÇÕº´(M&A) ºÐ¼®

Á¦12Àå ±â¾÷ °³¿ä

  • Atos Medical AB
    • ±â¾÷ °³¿ä
    • Á¦Ç° Æ÷Æ®Æú¸®¿À
      • Á¦Ç° ¼³¸í
      • Á¦Ç° Çٽɼº°úÁöÇ¥(KPI)
      • °ú°Å ¹× ¿¹Ãø Á¦Ç° ÆÇ¸Å
      • Á¦Ç° ÆÇ¸Å·®
    • À繫 °³¿ä
      • ȸ»ç ¸ÅÃâ
      • Áö¿ªº° ¸ÅÃ⠺йè
      • ¸ÅÃâ ¿¹Ãø
    • ÁÖ¿ä ¹ßÀü
      • ÀμöÇÕº´(M&A)
      • ÁÖ¿ä Á¦Ç° °³¹ß Ȱµ¿
      • ±ÔÁ¦±â°ü ½ÂÀεî
    • SWOT ºÐ¼®
  • Preceptis Medical
  • Smith+Nephew
  • Medasil Surgical Limited
  • Cape Medical Group
  • SPIGGLE & THEIS Medizintechnik GmbH
  • Bryan Medical Inc.
  • EON Meditech
  • Grace Medical
  • Summit Medical LLC.

Á¦13Àå ºÎ·Ï

LSH 25.03.07

The global tympanostomy products market reached US$ 98.76 million in 2024 and is expected to reach US$ 132.76 million by 2033, growing at a CAGR of 3.37% during the forecast period 2025-2033.

Tympanostomy is a medical procedure commonly used to treat chronic ear infections and fluid buildup in the middle ear, often in children. During the procedure, a small incision is made in the eardrum to allow for the drainage of fluid and to insert a small tube, known as a ventilation tube or ear tube, to keep the middle ear ventilated. This helps prevent further fluid accumulation and reduces the risk of recurrent infections, providing relief from pressure and pain.

The Tympanostomy products market includes various products used in the procedure, such as different types of ventilation tubes made from materials like silicone, titanium, and grommets. Other key products include surgical instruments for performing the incision, topical antibiotics to prevent infection, and anesthesia for patient comfort.

Market Dynamics: Drivers & Restraints

Rising Incidence of Ear Infections

The rising number of ear infections, particularly in children, is expected to significantly boost the Tympanostomy products market. Ear infections are a common problem in young children, and when they occur repeatedly, they can lead to complications like fluid buildup and even hearing loss. For instance, according to the report by the National Institute of Health in 2024, the global incidence of chronic suppurative otitis media (OM) is reported to be 4.76 per thousand, equating to approximately 31 million cases. Of these, 22.6% occur annually in children under the age of five. As these infections become more frequent, the demand for Tympanostomy procedures, which help prevent long-term issues and restore hearing, is growing. During this procedure, small ventilation tubes are inserted into the eardrum to allow the ear to drain properly and avoid future infections.

With more children needing Tympanostomy tubes and other related products, the market for these devices is set to expand. As awareness grows about the potential long-term effects of untreated ear infection the need for effective treatments becomes even more critical. Furthermore, as medical technology advances, new, less invasive ventilation tubes are being developed, improving patient outcomes and driving further growth in the market. This trend is expected to continue, especially as ear infections remain prevalent in young children.

Limited Awareness in Developing Regions

Limited awareness in developing regions can hinder the growth of the Tympanostomy products market by preventing patients and healthcare providers from recognizing the benefits of the procedure. In many low-income areas, there may be a lack of knowledge about the long-term advantages, such as preventing hearing loss and developmental delays in children. This can lead to the use of less effective treatments affecting the overall market growth.

Segment Analysis

The global tympanostomy products market is segmented based on product type, material type, application, end user, and region.

Product Type:

Tympanostomy tubes segment is expected to dominate the global tympanostomy products market share

The Tympanostomy tubes segment is expected to dominate the global Tympanostomy products market due to their essential role in the treatment of chronic ear infections and fluid buildup in the middle ear. These small, medical-grade tubes are inserted into the eardrum during a Tympanostomy procedure to help ventilate the ear and prevent future infections. As the most commonly used product in the procedure, Tympanostomy tubes are in high demand, especially among children who are more prone to recurrent ear infections.

The growing incidence of ear infections and the increasing awareness of the long-term effects of untreated conditions, such as hearing loss or speech delays, are driving this demand. Additionally, advances in tube design and materials are making these tubes more effective and easier to use, leading to greater adoption among healthcare professionals.

With continuous improvements in technology and a larger patient population in need of these tubes, the Tympanostomy tubes segment is expected to maintain its dominant position in the global market. For instance, in March 2024, Innovia Medical has expanded their range of ENT Vent Tubes to the UK and EU markets.

Geographical Analysis

North America is expected to hold a significant position in the global tympanostomy products market share

North America is expected to maintain a strong position in the global tympanostomy products market due to a combination of high demand and advanced healthcare infrastructure. The region sees a high prevalence of ear infections, particularly among children, which drives the need for tympanostomy procedures to address chronic issues and prevent long-term complications like hearing loss. For instance, By the time they reach 3 years old, over 80% of children will have experienced at least one ear infection. In the United States, ear infections are responsible for approximately 30 million visits to paediatricians annually. As more children are diagnosed with frequent ear infections, the demand for tympanostomy tubes and related products is steadily increasing.

Moreover, North America's healthcare system is well-equipped with cutting-edge technologies, including state-of-the-art surgical instruments and advanced ventilation tubes that improve the effectiveness of the procedure. The region also benefits from a strong focus on early intervention, with paediatricians frequently recommending Tympanostomy to prevent the developmental impacts of untreated ear infections, such as speech delays.

Furthermore, ongoing research and development in North America continue to drive innovation in Tympanostomy tube design, making them more effective, durable, and minimally invasive. Companies in the regions are expanding their availability across various regions. For instance, in December 2023, Preceptis Medical, Inc. announced that children will have expanded access to the Hummingbird in-office ear tube procedure through a collaboration with one of the largest Medicaid payers in the United States. These factors, combined with favourable insurance coverage and access to healthcare, ensure that North America will continue to lead the global Tympanostomy products market.

Competitive Landscape

The major global players in the tympanostomy products market include Atos Medical AB, Preceptis Medical, Smith+Nephew, Medasil Surgical Limited, Cape Medical Group, SPIGGLE & THEIS Medizintechnik GmbH, Bryan Medical Inc., EON Meditech, Grace Medical and Summit Medical LLC. among others.

Key Developments

  • In August 2024, AventaMed, a KARL STORZ company, has received U.S. Food and Drug Administration 510(k) clearance for its Solo+ ear-tube placement device. The Solo+ device integrates several steps into a single tool, offering a more streamlined approach for performing office-based tympanostomies.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Tympanostomy Products Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Material Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Incidence of Ear Infections
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Awareness in Developing Regions
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis
  • 5.6. SWOT Analysis
  • 5.7. Unmet Needs

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Tympanostomy Tubes*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Tube Applicators / Inserters
  • 6.4. Others

7. By Material Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.1.2. Market Attractiveness Index, By Material Type
  • 7.2. Titanium*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Fluoroplastic
  • 7.4. Silicone
  • 7.5. Stainless Steel
  • 7.6. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Chronic Otitis Media*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Recurrent Acute Otitis Media
  • 8.4. Eustachian Tube Dysfunction
  • 8.5. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Specialty Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

  • 12.1. Atos Medical AB*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. Preceptis Medical
  • 12.3. Smith+Nephew
  • 12.4. Medasil Surgical Limited
  • 12.5. Cape Medical Group
  • 12.6. SPIGGLE & THEIS Medizintechnik GmbH
  • 12.7. Bryan Medical Inc.
  • 12.8. EON Meditech
  • 12.9. Grace Medical
  • 12.10. Summit Medical LLC.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦